Please login to the form below

Not currently logged in
Email:
Password:

black box warning

This page shows the latest black box warning news and features for those working in and with pharma, biotech and healthcare.

FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz

FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz

In 2019, the FDA released a formal warning in response to initial results that showed an increased risk of blood clots and death with the higher dose. ... At that time, the US drugs regulator issued a black box warning to the prescribing information for

Latest news

More from news
Approximately 1 fully matching, plus 53 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...